Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events
| dc.contributor.author | Wu F | |
| dc.contributor.author | Juonala M | |
| dc.contributor.author | Jacobs DR Jr | |
| dc.contributor.author | Daniels SR | |
| dc.contributor.author | Kähönen M | |
| dc.contributor.author | Woo JG | |
| dc.contributor.author | Sinaiko AR | |
| dc.contributor.author | Viikari JSA | |
| dc.contributor.author | Bazzano LA | |
| dc.contributor.author | Burns TL | |
| dc.contributor.author | Steinberger J | |
| dc.contributor.author | Urbina EM | |
| dc.contributor.author | Venn AJ | |
| dc.contributor.author | Raitakari OT | |
| dc.contributor.author | Dwyer T | |
| dc.contributor.author | Magnussen CG | |
| dc.contributor.organization | fi=InFLAMES Lippulaiva|en=InFLAMES Flagship| | |
| dc.contributor.organization | fi=sisätautioppi|en=Internal Medicine| | |
| dc.contributor.organization | fi=sydäntutkimuskeskus|en=Cardiovascular Medicine (CAPC)| | |
| dc.contributor.organization | fi=tyks, vsshp|en=tyks, varha| | |
| dc.contributor.organization | fi=väestötutkimuskeskus|en=Centre for Population Health Research (POP Centre)| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.35734063924 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.40502528769 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.42471027641 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.68445910604 | |
| dc.converis.publication-id | 182487870 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/182487870 | |
| dc.date.accessioned | 2025-08-28T00:20:48Z | |
| dc.date.available | 2025-08-28T00:20:48Z | |
| dc.description.abstract | <p><strong>Background: </strong>Although low-density lipoprotein cholesterol (LDL-C) remains the primary cholesterol target in clinical practice in children and adults, non-high-density lipoprotein cholesterol (non-HDL-C) has been suggested as a more accurate measure of atherosclerotic cardiovascular disease (ASCVD) risk. We examined the associations of childhood non-HDL-C and LDL-C levels with adult ASCVD events and determined whether non-HDL-C has better utility than LDL-C in predicting adult ASCVD events.</p><p><strong>Methods: </strong>This prospective cohort study included 21 126 participants from the i3C Consortium (International Childhood Cardiovascular Cohorts). Proportional hazards regressions were used to estimate the risk for incident fatal and fatal/nonfatal ASCVD events associated with childhood non-HDL-C and LDL-C levels (age- and sex-specific <em>z</em> scores; concordant/discordant categories defined by guideline-recommended cutoffs), adjusted for sex, Black race, cohort, age at and calendar year of child measurement, body mass index, and systolic blood pressure. Predictive utility was determined by the C index.</p><p><strong>Results: </strong>After an average follow-up of 35 years, 153 fatal ASCVD events occurred in 21 126 participants (mean age at childhood visits, 11.9 years), and 352 fatal/nonfatal ASCVD events occurred in a subset of 11 296 participants who could be evaluated for this outcome. Childhood non-HDL-C and LDL-C levels were each associated with higher risk of fatal and fatal/nonfatal ASCVD events (hazard ratio ranged from 1.27 [95% CI, 1.14-1.41] to 1.35 [95% CI, 1.13-1.60] per unit increase in the risk factor <em>z</em> score). Non-HDL-C had better discriminative utility than LDL-C (difference in C index, 0.0054 [95% CI, 0.0006-0.0102] and 0.0038 [95% CI, 0.0008-0.0068] for fatal and fatal/nonfatal events, respectively). The discordant group with elevated non-HDL-C and normal LDL-C had a higher risk of ASCVD events compared with the concordant group with normal non-HDL-C and LDL-C (fatal events: hazard ratio, 1.90 [95% CI, 0.98-3.70]; fatal/nonfatal events: hazard ratio, 1.94 [95% CI, 1.23-3.06]).</p><p><strong>Conclusions: </strong>Childhood non-HDL-C and LDL-C levels are associated with ASCVD events in midlife. Non-HDL-C is better than LDL-C in predicting adult ASCVD events, particularly among individuals who had normal LDL-C but elevated non-HDL-C. These findings suggest that both non-HDL-C and LDL-C are useful in identifying children at higher risk of ASCVD events, but non-HDL-C may provide added prognostic information when it is discordantly higher than the corresponding LDL-C and has the practical advantage of being determined without a fasting sample.</p> | |
| dc.format.pagerange | 217 | |
| dc.format.pagerange | 226 | |
| dc.identifier.jour-issn | 0009-7322 | |
| dc.identifier.olddbid | 205554 | |
| dc.identifier.oldhandle | 10024/188581 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/55344 | |
| dc.identifier.url | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.064296 | |
| dc.identifier.urn | URN:NBN:fi-fe2025082787037 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Juonala, Markus | |
| dc.okm.affiliatedauthor | Viikari, Jorma | |
| dc.okm.affiliatedauthor | Raitakari, Olli | |
| dc.okm.affiliatedauthor | Magnussen, Costan | |
| dc.okm.affiliatedauthor | Dataimport, tyks, vsshp | |
| dc.okm.discipline | 3121 Internal medicine | en_GB |
| dc.okm.discipline | 3121 Sisätaudit | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher.country | United States | en_GB |
| dc.publisher.country | Yhdysvallat (USA) | fi_FI |
| dc.publisher.country-code | US | |
| dc.relation.doi | 10.1161/CIRCULATIONAHA.123.064296 | |
| dc.relation.ispartofjournal | Circulation | |
| dc.relation.issue | 3 | |
| dc.relation.volume | 149 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/188581 | |
| dc.title | Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events | |
| dc.year.issued | 2024 |
Tiedostot
1 - 1 / 1
Ladataan...
- Name:
- FeitongEtal2023ChildhoodNon-HDLCholesterol.pdf
- Size:
- 551.79 KB
- Format:
- Adobe Portable Document Format